Document Classification

Section Type: RESULTS

Text: VGB treatment had no influence on antipyrine clearance (28 + / - 5. 6 vs. 30 + / - 4. 5 ml/h/kg on placebo), antipyrine half-life (15. 5 + / - 3. 5 vs. 14. 1 + / - 2. 1 h), urinary 6-beta-hydroxycortisol excretion (488 + / - 164 vs. 470 + / - 228 nmol / day), 6-beta-hydroxycortisol-to-cortisol concentration ratio (6. 8 + / - 3. 1 vs. 6. 1 + / - 3. 1) and serum gamma-glutamyltransferase activity (12 + / - 3 vs. 11 + / - 3 IU/L).